Literature DB >> 2219213

Pharmacologic irreversible narrowing in chronic cerebrovasospasm in rabbits is associated with functional damage.

P Vorkapic1, R D Bevan, J A Bevan.   

Abstract

We studied isolated basilar artery segments from a rabbit model of chronic cerebrovasospasm. Autologous blood placed around the basilar artery of rabbits killed 1, 2, 3, 4, 5, 6, 7, or 9 days later caused narrowing of the segments with a biphasic time course. The first (immediate) phase was reversed by intra-arterial papaverine; the second phase exhibited an increasing component of narrowing that was papaverine-insensitive. Based on the passive force/length curves, basilar artery segments became increasingly stiff over 9 days. By contrast, the segments' contractility decreased. Responses of the basilar artery segments were greater over the first few days, but then became less than that of saline-injected controls. Contractions in response to norepinephrine and potassium were reduced. Endothelium-based acetylcholine-induced vasodilation progressively diminished, as did the response to sympathetic nerve stimulation. There was a negative correlation between artery wall stiffness and contractility. The papaverine-insensitive component of angiographic narrowing correlated directly with loss of contractility and with artery wall stiffness. These results are consistent with the conclusion that increased artery wall stiffness is a primary determining factor in the arterial narrowing of chronic cerebrovasospasm.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2219213     DOI: 10.1161/01.str.21.10.1478

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  2 in total

1.  Selective intraarterial nimodipine treatment in an experimental subarachnoid hemorrhage model.

Authors:  M Murat Firat; Veli Gelebek; Hakan S Orer; Deniz Belen; Ahmet K Firat; Ferhun Balkanci
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

2.  Role of vascular mitogens in subarachnoid hemorrhage-associated cerebral vasculopathy.

Authors:  Cheryl A Miller; Frederick W Lombard; Ching-Tang Wu; Cory J Hubbard; Lydia Silbajoris; Cecil O Borel; Laura E Niklason
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.